Translation initiation: a critical signalling node in cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Signaling

Background:

• Mammalian target of rapamycin (mTOR) regulates protein synthesis, crucial for cell growth and proliferation.
• Dysregulation of the mTOR pathway and translation initiation is implicated in various human cancers.
• mTOR signaling is a convergence point for multiple oncogenic pathways.

Purpose of the Study:

• To review the literature on mTOR pathway activation in human cancers.
• To highlight the role of mTOR and translation initiation in oncogenesis.
• To evaluate targeting mTOR as a therapeutic strategy.

Main Methods:

• Literature review of genome-wide analyses and signaling pathway research.
• Analysis of the role of mTOR, S6K, and eIF4E/4E-BP in cancer.
• Synthesis of evidence implicating mTOR in the transformation phenotype.

Main Results:

• Widespread activation of mTOR/eIF4E is observed in transformed cells.
• mTOR pathway activation contributes significantly to the cancer cell phenotype.
• Inhibiting mTOR shows potential as an anti-proliferative approach.

Conclusions:

• Targeting translation initiation is a logical therapeutic strategy for broad-acting anti-cancer effects.
• mTOR pathway activation is a common feature across various cancers.
• Further research into mTOR inhibitors is warranted for cancer therapy.